AMR101

Horizon Pharma (NASDAQ: HZNP) and Amarin (NASDAQ: AMRN) both have upcoming Prescription Drug User Fee Act dates on Thursday. PDUFA refers to the fees that the FDA collects from drug manufacturers and allocates towards a drug's review process. The FDA traditionally makes an effort to complete its...

On Tuesday, the FDA approved the second weight-loss drug in the last 13 years when it green-lighted Vivus' drug Qsymia. On Wednesday, VVUS shares have shot up more than 14 percent to $30.27. The approval of this drug and the excitement that it has created in the biotech investing community may...